Yahoo Web Search

  1. United Therapeutics UTHR reported earnings of $3.01 per share for the third quarter of 2019, which beat the Zacks Consensus Estimate of $2.34. Revenues for the reported quarter were $401.5 million ...

  2. AASLD Presentations Cocrystal Pharma Inc (NASDAQ: COCP): new Phase 2a data for CC-31244 in hepatitis C (Sunday). Mallinckrodt PLC (NYSE: MNK): already-released Phase 3 data for terlipressin ...